NPTH — NeuPath Health Cashflow Statement
0.000.00%
Last trade - 00:00- CA$31.46m
- CA$40.46m
- CA$87.19m
Annual cashflow statement for NeuPath Health, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -3.23 | -4.28 | -0.191 | -0.485 | -0.413 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 1.16 | 2.14 | 0.104 | 0.895 | 0.783 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.18 | 0.241 | 0.555 | -0.04 | 1.3 |
| Change in Accounts Receivable | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 1.92 | 0.738 | 3.03 | 2.61 | 4 |
| Capital Expenditures | -0.411 | -1.67 | -0.353 | -0.948 | -0.863 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -3.09 | 0 | 1.94 | -0.159 | 0 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Change in Net Intangibles | |||||
| Cash from Investing Activities | -3.5 | -1.67 | 1.59 | -1.11 | -0.863 |
| Financing Cash Flow Items | — | — | — | 0.122 | -1.36 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -3.37 | -3.45 | -2.96 | -1.75 | -1.59 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -4.95 | -4.39 | 1.66 | -0.254 | 1.55 |